LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.

Wang J, Gao J, Chen Q, Zou W, Yang F, Wei C, Wang Z

DOI: 10.2147/ott.s244879
Published: 2020
Container: OncoTargets and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ott.s244879,
  title = {LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.},
  author = {Wang J and Gao J and Chen Q and Zou W and Yang F and Wei C and Wang Z},
  year = {2020},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s244879},
  url = {https://doi.org/10.2147/ott.s244879}
}

RIS

TY  - JOUR
TI  - LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.
AU  - Wang J
AU  - Gao J
AU  - Chen Q
AU  - Zou W
AU  - Yang F
AU  - Wei C
AU  - Wang Z
PY  - 2020
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s244879
UR  - https://doi.org/10.2147/ott.s244879
ER  -

APA

J, W., J, G., Q, C., W, Z., F, Y., C, W., & Z, W. (2020). LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.. OncoTargets and therapy. https://doi.org/10.2147/ott.s244879

Source records

pubmed · retrieved 2026-09-24T23:24:38.754Z